Project List
List projects.
Fields
id (integer)
Primary key.
Expansions
To activate relation expansion add the desired fields as a comma separated
list to the expand query parameter like this:
?expand=<field>,<field>,<field>,...
The following relational fields can be expanded:
organizationcategorytypepartner_functionmanagercontactstatusgrantresearcheventstudylanguageprogramfunders
Filters
To filter for exact value matches:
?<fieldname>=<value>
Possible exact filters:
organizationcategorymanagercontactstatusgrantresearchstudylanguagefundersprogram
For advanced filtering use lookups:
?<fieldname>__<lookup>=<value>
All fields with advanced lookups can also be used for exact value matches as described above.
Possible advanced lookups:
begin_planned:gt,gte,lt,ltebegin_effective:gt,gte,lt,lteend_planned:gt,gte,lt,lteend_effective:gt,gte,lt,lte
GET /v1/research/project/?format=api&offset=1360&ordering=end_effective
{ "count": 2265, "next": "https://api-test.medunigraz.at/v1/research/project/?format=api&limit=20&offset=1380&ordering=end_effective", "previous": "https://api-test.medunigraz.at/v1/research/project/?format=api&limit=20&offset=1340&ordering=end_effective", "results": [ { "id": 6053, "title": { "de": "HDHL-INTIMIC: Knowledge Platform on Food, Diet, Intestinal Microbiomics and Human Health", "en": "HDHL-INTIMIC: Knowledge Platform on Food, Diet, Intestinal Microbiomics and Human Health" }, "short": "JPI KP", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2019-06-01T02:00:00+02:00", "begin_effective": "2019-06-01T02:00:00+02:00", "end_planned": "2021-05-30T02:00:00+02:00", "end_effective": "2022-05-30T02:00:00+02:00", "assignment": "2020-02-12T10:56:07+01:00", "program": null, "subprogram": null, "organization": 14020, "category": 10, "type": 10, "partner_function": 3, "manager": null, "contact": null, "status": 2, "research": 5, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 416 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [] }, { "id": 6317, "title": { "de": "Referenzmodell für ein kollaboratives Daten-, Informations- und Wissensmanagement im regionalen und europäischen Kontext", "en": "Referenzmodell für ein kollaboratives Daten-, Informations- und Wissensmanagement im regionalen und europäischen Kontext" }, "short": "REGIO Data", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2020-05-01T02:00:00+02:00", "begin_effective": "2020-09-01T02:00:00+02:00", "end_planned": "2021-12-31T01:00:00+01:00", "end_effective": "2022-05-31T02:00:00+02:00", "assignment": "2020-10-22T11:27:30+02:00", "program": null, "subprogram": null, "organization": 14020, "category": 10, "type": 10, "partner_function": 2, "manager": 51663, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 135 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "6317-51663-10" ] }, { "id": 5197, "title": { "de": "HHcy und Atherosklerose: Molekulare Mechanismen und Pathophysiologie", "en": "Hyperhomocysteinemia and atherosclerosis: molecular mechanisms and pathophysiology" }, "short": null, "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2018-01-01T01:00:00+01:00", "begin_effective": "2018-04-01T02:00:00+02:00", "end_planned": "2022-12-31T01:00:00+01:00", "end_effective": "2022-05-31T02:00:00+02:00", "assignment": "2018-01-10T14:05:54+01:00", "program": 72, "subprogram": null, "organization": 14028, "category": 10, "type": 10, "partner_function": 2, "manager": 52854, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 9 ], "funder_projectcode": "P31105 ", "ethics_committee": null, "edudract_number": null, "persons": [ "5197-52854-10", "5197-56571-12" ] }, { "id": 5688, "title": { "de": "MikroRNA-abhängige Regulation des Hedgehog Signalwegs in Lungen Adenokarzinomzellen", "en": "MicroRNA-mediated regulation of hedgehog signaling pathway in lung adenocarcinoma cells" }, "short": "Hedgehog pathway in lung adenocarcinoma", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2019-01-01T01:00:00+01:00", "begin_effective": "2019-04-01T02:00:00+02:00", "end_planned": "2019-12-31T01:00:00+01:00", "end_effective": "2022-05-31T02:00:00+02:00", "assignment": "2019-02-14T14:06:29+01:00", "program": null, "subprogram": null, "organization": 14087, "category": 10, "type": 10, "partner_function": 4, "manager": 50610, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 1765 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "5688-50610-10" ] }, { "id": 6604, "title": { "de": "MICU1 reguliert mitochondriale Bioenergetik durch Ca2+ abhängige Kontrolle der \"Cristae Junction\" und des mitochondrialen Membranepotentials", "en": "MICU1 regulates mitochondrial bioenergetics by Ca2+-dependent control of the cristae junction and mitochondrial membrane potential \r\n" }, "short": null, "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2021-06-01T02:00:00+02:00", "begin_effective": "2021-06-01T02:00:00+02:00", "end_planned": "2021-06-01T02:00:00+02:00", "end_effective": "2022-05-31T02:00:00+02:00", "assignment": "2021-05-31T13:19:58+02:00", "program": null, "subprogram": null, "organization": 14013, "category": 10, "type": 10, "partner_function": 4, "manager": 90394, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 1743 ], "funder_projectcode": "MEFO-64", "ethics_committee": null, "edudract_number": null, "persons": [ "6604-90394-10" ] }, { "id": 7147, "title": { "de": "EASI Genomics - Single cell multi-omics Untersuchung des Effekts von Rauchen in der Frühschwangerschaft", "en": "EASI Genomics - Smoking and its effect on early gestational development in a single-cell multi-omics approach; SMOKING – Single-cell Multi-Omics developmental KINetics in early Gestation" }, "short": "SMOKING", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2021-09-01T02:00:00+02:00", "begin_effective": "2021-09-01T02:00:00+02:00", "end_planned": "2022-06-01T02:00:00+02:00", "end_effective": "2022-05-31T02:00:00+02:00", "assignment": "2022-08-26T11:04:26+02:00", "program": null, "subprogram": null, "organization": 14017, "category": 10, "type": 10, "partner_function": 3, "manager": 89664, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 10 ], "funder_projectcode": "PID15215", "ethics_committee": null, "edudract_number": null, "persons": [ "7147-89664-10" ] }, { "id": 6843, "title": { "de": "Zusatzfinanzierung Projekte \"HerzSache\" und \"Marko, der Makrophage\"", "en": "Additional funding for projects \"Heart Matters\" und \"Marko, the Macrophage\"" }, "short": null, "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2021-05-01T02:00:00+02:00", "begin_effective": "2021-05-01T02:00:00+02:00", "end_planned": "2021-04-30T02:00:00+02:00", "end_effective": "2022-06-30T02:00:00+02:00", "assignment": "2021-12-16T10:40:15+01:00", "program": null, "subprogram": null, "organization": 14013, "category": 10, "type": 10, "partner_function": 4, "manager": 79755, "contact": null, "status": 2, "research": 5, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 2160 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "6843-79755-10" ] }, { "id": 6892, "title": { "de": "Anpassung der mitochondrialen Ultrastruktur an die lokale Mikroumgebung in Krebszellen", "en": "Adaption of the mitochondrial ultrastructure to the local micro environment in cancer cells" }, "short": null, "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2022-02-01T01:00:00+01:00", "begin_effective": "2022-02-01T01:00:00+01:00", "end_planned": "2022-06-01T02:00:00+02:00", "end_effective": "2022-06-30T02:00:00+02:00", "assignment": "2022-01-24T12:00:26+01:00", "program": null, "subprogram": null, "organization": 14013, "category": 10, "type": 10, "partner_function": 4, "manager": 90394, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 1743 ], "funder_projectcode": "MEFO-71", "ethics_committee": null, "edudract_number": null, "persons": [ "6892-90394-10" ] }, { "id": 6881, "title": { "de": "Biomarker für kardiovaskuläre Risiken und neurodegenerative Erkrankungen nach insulininduzierter Hypoglykämie", "en": "Biomarkers for cardiovascular risk and neurodegenerative disease following insulin-induced hypoglycaemia" }, "short": null, "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2021-12-01T01:00:00+01:00", "begin_effective": "2021-12-01T01:00:00+01:00", "end_planned": "2022-06-30T02:00:00+02:00", "end_effective": "2022-06-30T02:00:00+02:00", "assignment": "2022-01-17T15:13:04+01:00", "program": null, "subprogram": null, "organization": 14080, "category": 10, "type": 10, "partner_function": 1, "manager": 100944, "contact": null, "status": 2, "research": 4, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 151 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "6881-78894-11", "6881-100944-10" ] }, { "id": 6849, "title": { "de": "Immunantwort und konjunktivale bakterielle Flora bei Patient*innen mit moderater bis schwerer atopischer Dermatitis unter Dupilumab-Therapie – Pilot-Studie", "en": "Immune response and conjunctival bacterial flora in patients with moderate to severe atopic dermatitis treated with dupilumab – pilot trial" }, "short": "Dr. Adele-Rabensteiner-Preis der ÖOG", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2019-08-01T02:00:00+02:00", "begin_effective": "2019-08-01T02:00:00+02:00", "end_planned": "2022-06-30T02:00:00+02:00", "end_effective": "2022-06-30T02:00:00+02:00", "assignment": "2021-12-17T14:28:12+01:00", "program": null, "subprogram": null, "organization": 14043, "category": 10, "type": 10, "partner_function": 2, "manager": 83662, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 2194 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "6849-83662-10" ] }, { "id": 6204, "title": { "de": "Der Einfluss pflanzlicher Ernährung auf die Immunmodulation. \r\nEffekte elektiver natürlicher Pflanzenfarbstoffe und der Lebensmittelmatrix auf die Aryl-Hydrocarbon-Rezeptor Aktivität.\r\n", "en": "The impact of plant-based nutrition on Immunmodulation.\r\nSubtitle: Effects of elective natural dyes and food matrix on aryl hydrocarbon receptor interaction.\r\n" }, "short": null, "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2020-07-01T02:00:00+02:00", "begin_effective": "2020-07-01T02:00:00+02:00", "end_planned": "2020-11-30T01:00:00+01:00", "end_effective": "2022-06-30T02:00:00+02:00", "assignment": "2020-07-15T17:29:13+02:00", "program": null, "subprogram": null, "organization": 14014, "category": 10, "type": 10, "partner_function": 4, "manager": 88711, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 1743 ], "funder_projectcode": "MEFO-53", "ethics_committee": null, "edudract_number": null, "persons": [ "6204-88711-10" ] }, { "id": 4894, "title": { "de": "Postmortale Validatierung von Quantitative Susceptibility Mapping", "en": "Postmortem Validation of Quantitative Susceptibility Mapping" }, "short": "pmQSM", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2017-01-01T01:00:00+01:00", "begin_effective": "2017-04-01T02:00:00+02:00", "end_planned": "2019-12-31T01:00:00+01:00", "end_effective": "2022-06-30T02:00:00+02:00", "assignment": "2017-03-23T14:45:33+01:00", "program": 72, "subprogram": null, "organization": 14051, "category": 10, "type": 10, "partner_function": 4, "manager": 60116, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 9 ], "funder_projectcode": "P30134", "ethics_committee": null, "edudract_number": null, "persons": [ "4894-60116-10" ] }, { "id": 5467, "title": { "de": "Modifikation des Mikrobioms zur Verbesserung von Metabolismus, Darmbarriere und Entzündung bei kindlichem Neuroblastom", "en": "Modification of the intestinal microbiome to improve metabolism, gut barrier function and inflammation in neuroblastoma" }, "short": "Mikrobiom-Tumor", "url": null, "abstract": { "de": "HINTERGRUND: Im Rahmen von malignen Tumorerkrankungen kann es zu einem katabolen Zustandsbild mit Verlust von Fett- und Muskelgewebe kommen. Dieses geht mit erheblicher Morbidität und Mortalität einher und wird als Kachexie bezeichnet. Obwohl die volle Ausprägung selten ist, wird bei bis zu 50% der pädiatrischen Malignome eine Unterernährung diagnostiziert. Neben dem Tumor selbst können auch Nebenwirkungen der Chemotherapie schwerwiegende Probleme bereiten. So wird in bis zu 60% dieser Kinder eine Mukositis des Gastrointestinaltraktes beobachtet, die sich klinisch durch Übelkeit, Erbrechen, Durchfall oder Obstipation, Schmerzen und – im schlimmsten Fall – lebensbedrohlichen Entzündungsreaktionen kennzeichnet. Im Alltag kann das eine Reduktion der Chemotherapie oder einen Ausfall eines Zyklus mit reduzierter Effektivität der Chemotherapie erfordern. Bisher ist die Therapie der Mukositis rein symptomatisch. Rezente Untersuchungen des Antragsstellers haben im Mikrobiom von Mäusen mit Neuroblastom (einem malignen Tumor des Kindesalters) einen signifikanten Abfall der Lactobacilli beobachtet, der mit einem pro-inflammatorischen Zustandsbild, Kachexie und gesteigerter Darmpermeabilität einherging. In diesem Modell hat auch die Chemotherapie alleine eine Dysbiose mit Abfall der Lactobacilli ausgelöst, was ursächlich mit der Entstehung einer Mukositis in Verbindung stehen könnte. Insgesamt scheint das intestinale Mikrobiom einen erheblichen Bestandteil in der Entstehung von Kachexie und chemotherapie-induzierter Mukositis zu haben.\r\nZIEL: Ziel dieses Projektes ist es zu untersuchen, ob eine Manipulation des Mikrobioms mittels Präbiotika, Probiotika oder Bakteriozinen einen positiven Einfluss auf Entzündungsreaktion, Darmwandbarriere und Metabolismus bei Neuroblastomen hat. Zusätzlich soll beurteilt werden, ob die im Tiermodell beobachten mikrobiellen Veränderungen auch bei Kindern mit Neuroblastom beobachtet werden können.\r\nMETHODEN: Im tierexperimentellen Teil wird das bereits etablierte Neuroblastommodell verwendet um bei Mäusen eine Kachexie auszulösen. Zusätzlich wird einem Teil der Mäuse eine Chemotherapie verabreicht. Danach wird im ersten Arbeitspaket der Einfluss von Omni-Logic® Apfelpektin und Omni-Biotic® AAD auf diese Mäuse untersucht. Der Hauptfokus liegt dabei auf der Beurteilung des fäkalen Mikrobioms, des bakteriellen Metabolismus, der Darmwandbarriere, Mukositis, des Entzündungssystemes und des Metabolismus. In einem weiteren Arbeitspaket werden dann speziell auf die beobachteten Veränderungen des Mikrobioms ausgerichtete Bakteriozine und antimikrobielle Metabolite hergestellt, für die in-vivo Anwendung angepasst, und im gleichen Tiermodell angewendet. Im grundlagenwissenschaftlichen humanen Teil des Projektes wird untersucht, ob zwischen Kindern mit Neuroblastom und gesunden Kontrollen ein Unterschiede im Mikrobiom und im Profil der volatilen Gase in Stuhl und Atemluft besteht. Zusätzlich wird in diesem Paket durch serielle Messungen Fokus auf mögliche Veränderungen des intestinalen Mikrobioms im Verlauf der Chemotherapie gelegt.\r\nINNOVATIONSGEHALT: Um die Forschungsschwerpunkte dieses Projektes zu beurteilen, kommen hochmoderne Verfahren zur Anwendung. Insbesondere die Untersuchung der volatilen Gase in Stuhl und Atemluft ist auf diesem Gebiet neu und gibt wichtige, nicht-invasive Einblicke in die mikrobielle Besiedelung und damit indirekt auf Metabolismus und Entzündungsreaktion der PatientInnen. Die in diesem Projekt untersuchten Prä- und Probiotika sind bereits am Markt erhältlich. Sollte sich durch ihren Einsatz eine Reduktion der Tumor- oder Chemotherapie-bedingten Störungen des Entzündungssystems, der Darmwandbarriere und des Metabolismus ergeben, könnten diese Produkte zukünftig supportiv in der Anti-Tumortherapie angewendet werden und zur Reduktion der Morbidität beitragen. Der Therapieansatz mit Bakteriozinen ist wissenschaftliches Neuland. \r\n", "en": "BACKGROUND: Malignant tumors may lead to a catabolic state with loss of muscle and adipose tissue. The full picture of catabolism is termed cachexia and is associated with significant morbidity and mortality of cancer patients. Although the full picture is rarely observed up to 50% of children with cancer suffer from significant malnourishment. Additionally to tumor-induced catabolism, side-effects of chemotherapy may be problematic for the patients. In this regard up to 60% of children suffer from gastrointestinal mucositis presenting with nausea, vomiting, diarrhea or constipation and abdominal pain. In the worst case, mucositis may lead to bacterial translocation with life-threatening inflammatory response. Clinically this may require a reduction of the dosage or the number of chemotherapy cycles resulting in reduced effectivity. Up to now the therapy of mucositis is only symptomatic. Recent research of the applicant has shown a significant reduction of Lactobacilli in mice with neuroblastoma (a malignant childhood tumor). The dysbiosis was associated with catabolism, increased gut permeability and inflammation. Astonishingly, chemotherapy alone also lead to a significant reduction of Lactobacilli compared to sham mice, which may be linked to the development of mucositis clinically. Overall, the intestinal microbiome seems to play an essential role in the development of tumor-associated catabolism and chemotherapy-induced mucositis.\r\nAIM: The aim of this project is to determine if manipulation of the intestinal microbiome with prebiotics, probiotics and bacteriocins (also referred to as lantibiotics) exerts beneficial effects on inflammation, gut permeability and metabolism in a murine model of neuroblastoma. Additionally, a human work package should determine if the changes in the intestinal microbiome observed in mice can also be seen in children with neuroblastoma.\r\nMETHODS: An established neuroblastoma model will be used to cause cachexia in mice. Additionally, a group of animals will receive chemotherapy. One work package will analyze the effect of Omni-Logic® Apfelpektin (a prebiotic containing pectin oligosaccharides) and Omni-Biotic® AAD (a probiotic) on these mice. The main focus will be on the intestinal microbiome, bacterial metabolism , gut permeability , mucositis , inflammation and metabolism. Additionally, data gained on microbial alterations by tumor and chemotherapy will be used to select specific bacteriocins and bacterial metabolites to influence the microbiome. These substances will be prepared for in vivo testing and applied to the same animal model. A basic science human work package will address the question if there are differences in the intestinal microbiome and the volatile organic compound profile between children with neuroblastoma and healthy controls. Furthermore, serial investigations in children with neuroblastoma will assess whether of not these patients show alterations of the intestinal microbiome under chemotherapy.\r\nINNOVATIONS: In this project cutting edge technology will be used to gain information about the main research topics. Especially the examination of volatile organic compounds in relation to the other tests is novel in this research field and provides non-invasive information about bacterial metabolism and indirectly on the patients’ inflammatory system and metabolism. The pre- and probiotics tested in this project are available on the market. If they lead to a reduction of tumor- or chemotherapy-induced disturbances of inflammatory system, gut barrier or metabolism in this project they may be easily used as supportive measures in the anti-cancer therapy of the future. The use of bacteriocins has presently not been tested in this context. If these substances would prove effective then this project would be a first important milestone towards human application of bacteriocins.\r\n" }, "begin_planned": "2018-08-01T02:00:00+02:00", "begin_effective": "2018-09-01T02:00:00+02:00", "end_planned": "2021-07-31T02:00:00+02:00", "end_effective": "2022-06-30T02:00:00+02:00", "assignment": "2018-09-03T17:23:35+02:00", "program": 60, "subprogram": null, "organization": 14049, "category": 10, "type": 10, "partner_function": 4, "manager": 54087, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 416 ], "funder_projectcode": "867991", "ethics_committee": null, "edudract_number": null, "persons": [ "5467-50778-12", "5467-50881-12", "5467-54087-10", "5467-73734-12", "5467-90375-12", "5467-100457-12", "5467-102412-12" ] }, { "id": 6459, "title": { "de": "ERINHA-Advance - Access: Development of Next Generation SARS-CoV-2 Diagnostics", "en": "ERINHA-Advance - Access: Development of Next Generation SARS-CoV-2 Diagnostics" }, "short": "NESARSDia", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2020-11-16T01:00:00+01:00", "begin_effective": "2020-12-01T01:00:00+01:00", "end_planned": "2021-12-31T01:00:00+01:00", "end_effective": "2022-06-30T02:00:00+02:00", "assignment": "2021-02-15T15:10:51+01:00", "program": 109, "subprogram": null, "organization": 14020, "category": 10, "type": 10, "partner_function": 2, "manager": 51663, "contact": null, "status": 2, "research": 5, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 10 ], "funder_projectcode": "824061", "ethics_committee": null, "edudract_number": null, "persons": [ "6459-51663-10" ] }, { "id": 5553, "title": { "de": "Advancing European Research Infrastructure on Highly Pathogenic Agents", "en": "Advancing European Research Infrastructure on Highly Pathogenic Agents" }, "short": "ERINHA-Advance", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2018-09-01T02:00:00+02:00", "begin_effective": "2019-01-01T01:00:00+01:00", "end_planned": "2021-09-01T02:00:00+02:00", "end_effective": "2022-06-30T02:00:00+02:00", "assignment": "2018-11-21T09:34:04+01:00", "program": 109, "subprogram": "INFRADEV-03-2018-2019", "organization": 14020, "category": 10, "type": 10, "partner_function": 2, "manager": 51663, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 10 ], "funder_projectcode": "824061", "ethics_committee": null, "edudract_number": null, "persons": [ "5553-51663-10" ] }, { "id": 6628, "title": { "de": "Graz Study on Health & Aging-Auswertung der Pilotphase:\r\nDie Rolle von sozio-demographischen und Lifestyle Faktoren bei biologischen Altern\r\n", "en": "Graz Study on Health & Aging-Evaluation of the Pilotphase:\r\nThe role of socioeconomic and Lifestyle Factor at Biological Aging" }, "short": "GSHA_Pilot", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2021-07-01T02:00:00+02:00", "begin_effective": "2021-07-15T02:00:00+02:00", "end_planned": "2022-06-30T02:00:00+02:00", "end_effective": "2022-07-14T02:00:00+02:00", "assignment": "2021-06-22T11:26:55+02:00", "program": null, "subprogram": null, "organization": 14013, "category": 10, "type": 10, "partner_function": 4, "manager": 51912, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 2471 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "6628-51912-10" ] }, { "id": 4552, "title": { "de": "Die Rolle der Calmodulin Kinase II in der Herzinsuffizienz ", "en": "Calmodulin kinase II cascade in cardiac (patho)physiology" }, "short": "CaMKII und Herzinsuffizienz", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2016-10-01T02:00:00+02:00", "begin_effective": "2017-10-21T02:00:00+02:00", "end_planned": "2019-09-30T02:00:00+02:00", "end_effective": "2022-07-20T02:00:00+02:00", "assignment": "2016-08-09T14:57:20+02:00", "program": 87, "subprogram": null, "organization": 14083, "category": 10, "type": 10, "partner_function": 4, "manager": 62747, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 9 ], "funder_projectcode": "V 530-B27", "ethics_committee": null, "edudract_number": null, "persons": [ "4552-62747-10", "4552-75758-12" ] }, { "id": 6659, "title": { "de": "Antikörperrepertoires gegen das menschliche Mikrobiom", "en": "Antibody repertoires against the microbiome" }, "short": null, "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2021-07-19T02:00:00+02:00", "begin_effective": "2021-07-19T02:00:00+02:00", "end_planned": "2022-07-18T02:00:00+02:00", "end_effective": "2022-07-31T02:00:00+02:00", "assignment": "2021-08-02T11:19:26+02:00", "program": 69, "subprogram": null, "organization": 14023, "category": 10, "type": 10, "partner_function": 4, "manager": null, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 9 ], "funder_projectcode": "J 4256", "ethics_committee": null, "edudract_number": null, "persons": [] }, { "id": 5419, "title": { "de": "Potential der MRT 4D-Flussbildgebung zur Charakterisierung der diastolischen Herzfunktion", "en": "Potential role of MR 4D-Flow imaging for the characterization of diastology" }, "short": "CMR2018", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2018-08-01T02:00:00+02:00", "begin_effective": "2018-08-01T02:00:00+02:00", "end_planned": "2021-07-31T02:00:00+02:00", "end_effective": "2022-07-31T02:00:00+02:00", "assignment": "2018-07-17T13:49:17+02:00", "program": null, "subprogram": null, "organization": 14104, "category": 10, "type": 10, "partner_function": 4, "manager": 82111, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 12 ], "funder_projectcode": "17934", "ethics_committee": null, "edudract_number": null, "persons": [ "5419-82111-10" ] }, { "id": 6370, "title": { "de": "Untersuchung der Insulinabhängigen globalen und lokalen H2O2 und NO• Signaltransduktionswegen in Kardiomyozyten", "en": "Shining a Light on Global and Local H2O2 and NO• Signals in Cardiac Insulin Signaling" }, "short": "Insulin med. Radikalbldg. Herzmuskelzell", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2017-10-30T01:00:00+01:00", "begin_effective": "2021-02-01T01:00:00+01:00", "end_planned": "2020-10-30T01:00:00+01:00", "end_effective": "2022-07-31T02:00:00+02:00", "assignment": "2020-12-15T12:00:05+01:00", "program": 69, "subprogram": null, "organization": 14013, "category": 10, "type": 10, "partner_function": 4, "manager": null, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 9 ], "funder_projectcode": "J4113-B31", "ethics_committee": null, "edudract_number": null, "persons": [] } ] }